Bo Bichette exits Mets game with left foot contusion; X-rays negative

What happened

Bo Bichette departed a game after a foul ball struck his ankle, MLB.com reported. X-rays came back negative, the club announced, but Bichette's status going forward remains uncertain. The Mets have not indicated when he might be available to return.

A foul ball off the ankle is one of baseball's more unpleasant occupational hazards — the kind of thing that produces a negative X-ray and a very long night of ice packs. Negative imaging is genuinely good news, but soft-tissue damage can linger in ways that don't show up on film, and the Mets have been careful not to project a timeline.

The club described the injury as a left foot contusion. That diagnosis, paired with the negative imaging, suggests no structural damage but leaves the question of swelling, pain tolerance, and mobility unanswered. Those variables will determine whether this is a brief absence or something that requires a roster move.

Why it matters

Bichette arrived in New York as a recognizable name at shortstop, and any uncertainty around his availability carries real weight for a club already navigating a difficult stretch of the calendar. The Mets enter Thursday sitting fifth in the NL East, 20 games back in the division, and 10.5 games away from the Wild Card cut line — territory where the margin for roster disruption is essentially zero.

That context doesn't make the ankle hurt more or less, but it does sharpen the operational question. The Mets are not playing for a postseason berth in any conventional sense at this point in August, yet the games still count, the roster still has to be managed, and a shortstop who can't play is a problem regardless of the standings. Whether this is a one-day absence or something that requires a roster move is the question the club has not yet answered.

The timing is also awkward from a depth perspective. The Mets are operating with a 26-man roster through the end of August, and any injury that forces a lineup adjustment creates a cascade of decisions about who plays where and whether a corresponding move is necessary. September 1 brings roster expansion to 28 players, which would offer more flexibility, but that is still several days away.

Where the club stands

The Mets are 64-78 (.451), fifth in the NL East, and currently on a one-game losing streak. The Wild Card picture is equally unencouraging: they rank 10th relative to the cut line, sitting 10.5 games out.

The upcoming schedule at Citi Field offers a reasonable look at what the next few days demand. On Thursday, August 27, Sean Manaea takes the mound against Milwaukee's Jacob Misiorowski. Friday, August 28 opens a two-game set against the Houston Astros, with Christian Scott lined up against Hunter Brown. Saturday, August 29 continues that series, with Nolan McLean scheduled against Bennett Sousa.

Three home games across two series — Milwaukee and Houston — represent the immediate horizon. None of those matchups become easier with a question mark at shortstop, and the Mets will need to decide quickly whether Bichette can be available or whether a roster adjustment is warranted.

The pitching schedule is set, which is one less variable to manage. Manaea, Scott, and McLean are all listed as probables, and the Mets have not indicated any changes to that rotation. The defensive alignment behind them, however, could look different depending on how Bichette responds in the hours ahead.

What we don't know yet

The Mets have not provided a timetable for Bichette's return, and the nature of soft-tissue injuries around the ankle means that uncertainty is not just a communications posture — it reflects genuine variability in how these things heal. Negative X-rays tell you what isn't broken; they don't tell you how much it hurts to plant and pivot on a baseball field.

It is also not yet clear whether the club will make any roster move in response. Under general league rules, a position player can be placed on the 10-day injured list, which would open a 26-man roster spot and allow the Mets to add depth at shortstop or elsewhere. That decision has not been reported, and the Mets have not indicated it is forthcoming. The "status uncertain" framing from MLB.com suggests the club is still gathering information.

The distinction between a one-day absence and something longer is meaningful. If Bichette can play Thursday, the ankle held up well enough overnight and the club likely moves forward without a roster change. If he cannot, the Mets will need to decide whether to carry a player who is unavailable or to make a formal move that opens a spot for someone who can contribute immediately.

What to watch

The most immediate question is whether Bichette is in the lineup Thursday against Milwaukee. If he is, the ankle held up well enough overnight and the club likely moves forward without a roster change. If he is not, the next question is whether this becomes a multi-day absence — and at what point the Mets decide that a formal IL placement makes more sense than carrying a player who cannot play.

The shortstop position will bear watching across all three upcoming home games. The Mets' pitching matchups are set — Manaea, Scott, and McLean are all listed as probables — but the defensive alignment behind them could look different depending on how Bichette responds in the next stretch of hours.

MLB.com's report leaves the situation genuinely open. Negative X-rays are the best possible first-step news, and there is no diagnosis beyond the left foot contusion the club announced. What happens next depends on how Bichette feels when he wakes up Thursday morning — which is, as any player who has taken a foul ball off the ankle will tell you, a very different question than how he felt when the X-ray came back clean.

The Mets have not indicated any particular outcome, which is both honest and operationally prudent. Soft-tissue injuries around the foot and ankle are notoriously difficult to predict, and the club's reluctance to commit to a timeline reflects that reality. The next update will likely come in the form of a lineup card, or the absence of one, and that will tell the story more clearly than any statement issued Wednesday night.

For now, the Mets are waiting to see how the swelling responds, how the pain tolerance holds, and whether Bichette can move well enough to play shortstop at a major-league level. Those are the variables that will determine whether this is a brief scare or something that requires a roster adjustment heading into the final month of the season.